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Valorisation
Relevance
Most physicians have to deal with the prevention and treatment of infections and 
inflammations. The annual incidence of infection of the outer ear canal (external 
otitis) is about 1% of the population of the general practitioner1 and up to 10% at the 
otolaryngologist2. Chronic ear infection, due to an underlying condition, as eczema 
or after ear operations, have a high socioeconomic impact and cause significant 
health care costs3. In this patient group, the chronic or recurrent treatment with 
antibiotics causes an additional problem, which is bacterial resistance. The increase 
of bacterial resistance, together with a decrease in the development of new 
antibiotic agents, illustrated the need for new antiseptic strategies, as mentioned 
earlier.  
This thesis focuses on the use of the antiseptic agent honey, and it’s clinical 
relevance for patients with chronic ear infections. The refinement of medical 
honey for clinical use does not only offer a new treatment for patients with chronic 
ear infections, but additionally contributes to the important development of new 
alternatives in the fight against bacterial resistance. 
The results of this thesis offer an overview of the clinical applicability of medical 
honey in otorhinolaryngology, provide insights in properties and working 
mechanisms of different sorts of honey, and prove safety and effectiveness of 
honey treatment in patients with chronic ear infections. 
Target population
The results of this thesis are relevant for health care professionals, patients, as well 
as companies interested in drug research and development. Both clinical, and the 
histopathology study show for the first time, that honey can be used as a treatment 
in chronic ear infections. This is very important for care professionals and patients. 
For patients with chronic ear eczema or a chronically infected open mastoid cavity, 
this treatment offers a new safe strategy, which can be used after the failure of 
other therapies or as an additional treatment without disadvantages known from 
‘conventional’ treatments. Health care professionals are offered a whole new 
antiseptic strategy. Medical honey and honey droplets are available to buy and 
ready to use. 
In addition, the results of this thesis can be important for companies (profit and 
non-profit), who are involved in the development and refinement of antiseptic 
agents. We provide additional information on possible working mechanisms of 
526886-L-bw-Henatsch
Processed on: 26-7-2019 PDF page: 127
127
7
Valorisation
different sorts of honey, but also present an overview of a broad applicability (in 
our review) and show the additional option of safe use in ear infection in the form 
of a gel and droplets. 
Products
In this thesis we focused on three different products. Medical honey in its 
source form, honey gel, and honey droplets. To understand underlying working 
mechanisms, it was chosen to investigate the antiseptic effects and antioxidative 
potential of peroxide (Revamil) and non-peroxide (Manuka) medical source honeys. 
For clinical use honey was also tested in droplet (Otomel) and gel (Nasumel) form. 
Innovation, realisation and costs
In the systematic review, which is provided in this thesis, it was shown that there 
is no scientific literature about the use of medical honey as a topical treatment in 
ear infection. The clinical studies, which are presented in this thesis, are the first 
showing usefulness and safety of honey in these conditions. All products are 
already available, ready to use, with a simple applicability. We proved that honey 
droplets and honey gel are safe, with only minor adverse events. The costs of both, 
honey eardrops and honey gel, are low and comparable to common eardrops used 
for ear infections.
